Physician profile
Shailendra Das
NPI 1013235233
$23,152.29
in general payments reported to CMS, 2019-2025
19 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what 89% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $25.17 · 2021: $38.23 · 2022: $2,577 · 2023: $18K · 2024: $547 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $2,126 · Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,580.00 |
| Travel and Lodging | $2,126.24 |
| Food and Beverage | $1,315.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15,271.45 | 2022-2023 | Ofev |
| Olympus Corporation of The Americas | $3,510.04 | 2022-2025 | Spiration Valve System, Single Use Suction Valve (Sterile) |
| Boehringer Ingelheim International Gmbh | $2,425.00 | 2023 | Ofev |
| Abbvie INC. | $347.51 | 2019-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $249.45 | 2024-2025 | Lumryz |
| Regeneron Healthcare Solutions, INC. | $236.37 | 2023-2024 | Dupixent |
| Baxter Healthcare | $168.48 | 2023-2025 | Hillrom - Vest System Model 105 Home Care |
| Chiesi USA, INC. | $151.75 | 2019 | |
| Gilead Sciences, INC. | $144.63 | 2019-2022 | |
| Olympus America INC. | $139.44 | 2025 | |
| Sanofi Pasteur INC. | $124.98 | 2022 | |
| Glaxosmithkline, LLC. | $115.20 | 2024 | Nucala |
| Vertex Pharmaceuticals Incorporated | $100.20 | 2021-2025 | |
| Genentech, INC. | $43.58 | 2022 | |
| 3b Medical, INC. | $32.58 | 2023 | Luna |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $32.20 | 2024 | |
| Alcresta Therapeutics, INC. | $26.51 | 2022 | |
| Advanced Respiratory, INC | $25.17 | 2020 | |
| Erbe USA INC | $7.75 | 2025 | N/A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shailendra Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.